Autoantibody Discovery Using a Novel Microarray of Functional Proteins

16 Jan 2019

Recombinant protein expression is a fundamental technique that underpins clinical diagnostics, drug discovery and screening, vaccine development and pure research for elucidating mechanisms of disease development and progression. However, high-throughput production of correctly folded and functional, full-length human proteins has a very high failure rate. Protein folding is a highly complex process requiring a combination of an aqueous environment, chaperones, post-translational modifications and the formation of multimeric structures held together by covalent bonds. Any deviation from the correct sequence of events can result in a misfolded protein. Loss of protein function is directly linked to misfolding. Use of misfolded proteins in downstream assays and interactions studies can result in identification of false positive biomarkers.

IMMUNOME™ v4 Discovery Array Service

- High-throughput platform for autoantibody biomarker discovery and protein-protein interactions - Exploratory arrays capable of screening over 1600 proteins in quadruplicate - Picogram level sensitivity - Fully quantitative assay - Exceptional consistency and batch-to-batch reproducibility

(0)

IMMUNOME™ v4 Discovery Array Kit

- High-throughput platform for autoantibody biomarker discovery and   protein-protein interactions - Exploratory arrays capable of screening   over 1600 proteins in quadruplicate - Picogram level sensitivity - fully quantitative  assay - Exceptional consistency and batch-to-batch   reproducibility

(0)

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Recombinant Proteins
Autoantibody Discovery Using a Novel Microarray of Functional Proteins